Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.29
+0.06 (0.96%)
At close: Jun 26, 2026, 4:00 PM EDT
6.34
+0.05 (0.79%)
After-hours: Jun 26, 2026, 5:08 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $574.73 million as of June 26, 2026. Its market cap has decreased by -24.89% in one year.
Market Cap
574.73M
Enterprise Value
525.74M
1-Year Change
-24.89%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $574.73M, an increase of 11.51%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 574.73M | -10.43% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 606.40M |
| SL Science Holding | 606.09M |
| Tectonic Therapeutic | 603.63M |
| BridgeBio Oncology Therapeutics | 592.79M |
| Faeth Therapeutics | 589.56M |
| Monopar Therapeutics | 587.35M |
| MiMedx Group | 585.36M |
| First Tracks Biotherapeutics | 559.32M |